Vanda Pharmaceuticals Inc.
DE ˙ DB ˙ US9216591084
5,26 € ↑0,09 (1,74%)
2026-06-05
DEL PRIS
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionDeutsche Bank Ag\
Latest Disclosed Ownership57,573 shares
Latest Disclosed Value $ 397,829
Deutsche Bank Ag\ ownership in VM4 / Vanda Pharmaceuticals Inc.

On May 6, 2026 - Deutsche Bank Ag\ filed a 13F-HR form disclosing ownership of 57,573 shares of Vanda Pharmaceuticals Inc. (DE:VM4) valued at $331,045 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 50,284 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of 14.50% during the quarter. The current value of the position is $302,834 USD.

Deutsche Bank Ag\ has a history of taking positions in derivatives of the underlying security (VM4) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:VM4 / Vanda Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F VANDA PHARMACEUTICALS COM 921659108 57,573 7,289 14.50 398 -10.38 0.0000
2026-02-11 2025-12-31 13F VANDA PHARMACEUTICALS COM 921659108 50,284 -352 -0.70 444 75.79 0.0001
2025-11-13 2025-09-30 13F VANDA PHARMACEUTICALS COM 921659108 50,636 50,636 253 0.0001
2025-08-12 2025-06-30 13F VANDA PHARMACEUTICALS COM 921659108 0 -62,417 -100.00 0 -100.00
2025-05-09 2025-03-31 13F VANDA PHARMACEUTICALS COM 921659108 62,417 -7,752 -11.05 286 -14.88 0.0001
2025-06-30 2024-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 70,169 24,792 54.64 336 58.49 0.0001
2025-02-14 2024-12-31 13F VANDA PHARMACEUTICALS COM 921659108 70,169 24,792 336 0.0001
2025-06-26 2024-09-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 45,377 10,706 30.88 213 8.72 0.0001
2024-11-13 2024-09-30 13F VANDA PHARMACEUTICALS COM 921659108 45,377 10,706 213 0.0001
2025-06-12 2024-06-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 34,671 -602 -1.71 196 35.42 0.0001
2024-08-14 2024-06-30 13F VANDA PHARMACEUTICALS COM 921659108 34,671 -602 196 0.0001
2025-06-02 2024-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 35,273 2,672 8.20 145 5.11 0.0001
2024-05-15 2024-03-31 13F VANDA PHARMACEUTICALS COM 921659108 35,273 2,672 145 0.0001
2024-02-14 2023-12-31 13F VANDA PHARMACEUTICALS COM 921659108 32,601 -7,150 -17.99 138 -19.88 0.0001
2023-11-24 2023-09-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 39,751 5,922 17.51 172 -22.97 0.0001
2023-11-09 2023-09-30 13F VANDA PHARMACEUTICALS COM 921659108 39,751 5,922 172 0.0000
2023-08-14 2023-06-30 13F VANDA PHARMACEUTICALS COM 921659108 33,829 -7,454 -18.06 223 -20.71 0.0001
2023-05-15 2023-03-31 13F VANDA PHARMACEUTICALS COM 921659108 41,283 -4,435 -9.70 280 -16.91 0.0002
2023-02-13 2022-12-31 13F VANDA PHARMACEUTICALS COM 921659108 45,718 6,416 16.32 338 -13.14 0.0002
2022-11-14 2022-09-30 13F VANDA PHARMACEUTICALS COM 921659108 39,302 -7,851 -16.65 388 -24.66 0.0002
2022-08-11 2022-06-30 13F VANDA PHARMACEUTICALS COM 921659108 47,153 -7,117 -13.11 515 -16.12 0.0003
2022-05-13 2022-03-31 13F VANDA PHARMACEUTICALS COM 921659108 54,270 -3,943 -6.77 614 -32.82 0.0003
2022-02-16 2021-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 58,213 -2,941 -4.81 914 -12.87 0.0004
2022-02-11 2021-12-31 13F VANDA PHARMACEUTICALS COM 921659108 58,213 -2,941 914 0.0000
2021-11-04 2021-09-30 13F VANDA PHARMACEUTICALS COM 921659108 61,154 -88,336 -59.09 1,049 -67.37 0.0005
2021-08-11 2021-06-30 13F VANDA PHARMACEUTICALS COM 921659108 149,490 -5,785 -3.73 3,215 37.86 0.0016
2021-05-13 2021-03-31 13F VANDA PHARMACEUTICALS COM 921659108 155,275 89,059 134.50 2,332 168.05 0.0013
2021-02-16 2020-12-31 13F VANDA PHARMACEUTICALS COM 921659108 66,216 15,846 31.46 870 79.01 0.0005
2020-11-12 2020-09-30 13F VANDA PHARMACEUTICALS COM 921659108 50,370 -42,638 -45.84 486 -54.28 0.0003
2020-08-13 2020-06-30 13F VANDA PHARMACEUTICALS COM 921659108 93,008 -369,337 -79.88 1,063 -77.80 0.0008
2020-05-14 2020-03-31 13F VANDA PHARMACEUTICALS COM 921659108 462,345 442,660 2,248.72 4,789 1,387.27 0.0043
2020-02-14 2019-12-31 13F VANDA PHARMACEUTICALS COM 921659108 19,685 -58,609 -74.86 322 -68.98 0.0002
2019-11-14 2019-09-30 13F VANDA PHARMACEUTICALS COM 921659108 78,294 -645,492 -89.18 1,038 -89.82 0.0007
2019-08-14 2019-06-30 13F VANDA PHARMACEUTICALS COM 921659108 723,786 595,055 462.25 10,197 330.80 0.0060
2019-05-15 2019-03-31 13F VANDA PHARMACEUTICALS COM 921659108 128,731 -10,542 -7.57 2,367 -34.94 0.0014
2019-04-01 2018-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 139,273 -183,962 -56.91 3,638 -50.96 0.0026
2019-02-14 2018-12-31 13F VANDA PHARMACEUTICALS COM 921659108 139,273 -79,273 3,638
2021-12-21 2018-09-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 323,235 188,172 139.32 7,419 188.34 0.0038
2018-11-14 2018-09-30 13F VANDA PHARMACEUTICALS COM 921659108 218,546 83,483 5,014 0.0035
2020-04-21 2018-06-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 135,063 74,385 122.59 2,573 152.01 0.0013
2018-08-14 2018-06-30 13F VANDA PHARMACEUTICALS COM 921659108 109,409 48,731 2,084 1,384.1876
2019-10-23 2018-03-31 13F/A-2 VANDA PHARMACEUTICALS COM 921659108 60,678 -52,034 -46.17 1,021 -40.36 0.0005
2019-10-18 2018-03-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 60,678 0 1,021 0.0005
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS COM 921659108 50,561 -62,151 850
2018-02-14 2017-12-31 13F VANDA PHARMACEUTICALS COM 921659108 112,712 -91,105 -44.70 1,712 -53.04 0.0011
2017-11-14 2017-09-30 13F VANDA PHARMACEUTICALS COM 921659108 203,817 -86,413 -29.77 3,646 -22.90 0.0025
2017-08-11 2017-06-30 13F VANDA PHARMACEUTICALS COM 921659108 290,230 -12,259 -4.05 4,729 11.72 0.0034
2017-05-15 2017-03-31 13F VANDA PHARMACEUTICALS COM 921659108 302,489 38,689 14.67 4,233 0.64 0.0031
2017-02-14 2016-12-31 13F VANDA PHARMACEUTICALS COM 921659108 263,800 36,321 15.97 4,206 11.15 0.0034
2016-11-14 2016-09-30 13F VANDA PHARMACEUTICALS COM 921659108 227,479 -99,286 -30.38 3,784 3.56 0.0027
2016-08-15 2016-06-30 13F VANDA PHARMACEUTICALS COM 921659108 326,765 -86,054 -20.85 3,654 5.91 0.0026
2016-05-16 2016-03-31 13F VANDA PHARMACEUTICALS COM 921659108 412,819 -18,411 -4.27 3,450 -14.05 0.0026
2016-02-16 2015-12-31 13F VANDA PHARMACEUTICALS COM 921659108 431,230 55,362 14.73 4,014 -5.29 0.0028
2015-11-17 2015-09-30 13F VANDA PHARMACEUTICALS COM 921659108 375,868 133,612 55.15 4,238 37.91 0.0033
2015-08-12 2015-06-30 13F VANDA PHARMACEUTICALS COM 921659108 242,256 -140,163 -36.65 3,073 -13.53 0.0020
2015-05-15 2015-03-31 13F VANDA PHARMACEUTICALS COM 921659108 382,419 126,021 49.15 3,554 -3.16 0.0022
2015-02-13 2014-12-31 13F VANDA PHARMACEUTICALS COM 921659108 256,398 72,714 39.59 3,670 92.65 0.0023
2014-11-14 2014-09-30 13F VANDA PHARMACEUTICALS COM 921659108 183,684 55,011 42.75 1,905 -8.41 0.0012
2014-08-15 2014-06-30 13F VANDA PHARMACEUTICALS COM 921659108 128,673 -235,173 -64.64 2,080 -64.81 0.0014
2014-05-15 2014-03-31 13F VANDA PHARMACEUTICALS COM 921659108 363,846 309,813 573.38 5,911 784.88 0.0042
2014-02-24 2013-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 54,033 -609,847 -91.86 668 -90.81 0.0005
2014-02-18 2013-12-31 13F VANDA PHARMACEUTICALS COM 921659108 54,033 668
2013-11-18 2013-09-30 13F VANDA PHARMACEUTICALS COM 921659108 663,880 663,880 7,269 0.0054
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-11-17 2015-09-30 13F VANDA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-12 2015-06-30 13F VANDA PHARMACEUTICALS COM Call 1,973 -76.47 25 -67.53 n/a n/a n/a
2015-05-15 2015-03-31 13F VANDA PHARMACEUTICALS COM Call 8,386 662.36 77 413.33 n/a n/a n/a
2015-02-13 2014-12-31 13F VANDA PHARMACEUTICALS COM Call 1,100 -41.43 15 -21.05 n/a n/a n/a
2014-11-14 2014-09-30 13F VANDA PHARMACEUTICALS COM Call 1,878 -56.45 19 -72.46 n/a n/a n/a
2014-08-15 2014-06-30 13F VANDA PHARMACEUTICALS COM Call 4,312 -58.96 69 666.67 n/a n/a n/a
2014-05-15 2014-03-31 13F VANDA PHARMACEUTICALS COM Call 10,507 50.92 9 28.57 n/a n/a n/a
2014-02-24 2013-12-31 13F/A VANDA PHARMACEUTICALS COM Call 6,962 77,255.56 7 0.00 n/a n/a n/a
2014-02-18 2013-12-31 13F VANDA PHARMACEUTICALS COM Call 6,962 7 n/a n/a n/a
2013-11-18 2013-09-30 13F VANDA PHARMACEUTICALS COM Call 9 0 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-02-24 2013-12-31 13F/A VANDA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2013-11-18 2013-09-30 13F VANDA PHARMACEUTICALS COM Put 1,000 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.